Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mariano Provencio

Showing results (1-10 of 391) with videos related to

Pageof 40
Sort By:
Annals of Translational Medicine|January 8, 2019
Treatment of induction in resectable NSCLC with chemotherapy, followed by surgery and erlotinibFernando Franco, Mariano Provencio
Journal of Thoracic Disease|November 19, 2019
Neoadjuvant treatment with tyrosine kinase inhibitors in patients with resectable non-small cell lung cancerFernando Franco, Mariano Provencio
Translational Lung Cancer Research|March 26, 2015
Therapeutic integration of new molecule-targeted therapies with radiotherapy in lung cancerMariano Provencio, Antonio Sánchez
Archivos De Bronconeumologia|October 15, 2025
Immunotherapy in Early-Stage Non-Small Cell Lung Cancer: A PRO/CON DebateMariano Provencio, Felipe Couñago
Medicina Clinica|January 29, 2008
[High-dose chemotherapy followed by autologous stem cell transplantation in non-Hodgkin's lymphoma]Mariano Provencio, Luis E Fayad
Chinese Clinical Oncology|June 12, 2023
Is there a role for first generation TKIs in adjuvant setting of EGFR mutated early NSCLC?Aylen Vanessa Ospina, Mariano Provencio
ESMO Open|May 16, 2020
How we treat patients with lung cancer during the SARS-CoV-2 pandemicMariano Provencio, Alberto Ruano-Raviña
Tumori|August 19, 2004
Gemcitabine in multi-resistant non-Hodgkin lymphomasEnric Carcereny, Pilar España, Mariano Provencio
Journal of Thoracic Disease|January 21, 2012
New molecular targeted therapies for advanced non-small-cell lung cancerMíriam Méndez, Ana Custodio, Mariano Provencio
The New England Journal of Medicine|October 18, 2023
Perioperative Nivolumab and Chemotherapy in Non-Small-Cell Lung Cancer. ReplyMariano Provencio, Bartomeu Massuti, Atocha Romero
Pageof 40

Showing results (1-10 of 391) with videos related to

Sort By:
Pageof 40
Annals of Translational Medicine|January 8, 2019
Treatment of induction in resectable NSCLC with chemotherapy, followed by surgery and erlotinibFernando Franco, Mariano Provencio
Journal of Thoracic Disease|November 19, 2019
Neoadjuvant treatment with tyrosine kinase inhibitors in patients with resectable non-small cell lung cancerFernando Franco, Mariano Provencio
Translational Lung Cancer Research|March 26, 2015
Therapeutic integration of new molecule-targeted therapies with radiotherapy in lung cancerMariano Provencio, Antonio Sánchez
Archivos De Bronconeumologia|October 15, 2025
Immunotherapy in Early-Stage Non-Small Cell Lung Cancer: A PRO/CON DebateMariano Provencio, Felipe Couñago
Medicina Clinica|January 29, 2008
[High-dose chemotherapy followed by autologous stem cell transplantation in non-Hodgkin's lymphoma]Mariano Provencio, Luis E Fayad
Chinese Clinical Oncology|June 12, 2023
Is there a role for first generation TKIs in adjuvant setting of EGFR mutated early NSCLC?Aylen Vanessa Ospina, Mariano Provencio
ESMO Open|May 16, 2020
How we treat patients with lung cancer during the SARS-CoV-2 pandemicMariano Provencio, Alberto Ruano-Raviña
Tumori|August 19, 2004
Gemcitabine in multi-resistant non-Hodgkin lymphomasEnric Carcereny, Pilar España, Mariano Provencio
Journal of Thoracic Disease|January 21, 2012
New molecular targeted therapies for advanced non-small-cell lung cancerMíriam Méndez, Ana Custodio, Mariano Provencio
The New England Journal of Medicine|October 18, 2023
Perioperative Nivolumab and Chemotherapy in Non-Small-Cell Lung Cancer. ReplyMariano Provencio, Bartomeu Massuti, Atocha Romero
Pageof 40